韓國産 Stem Cell Therapy, Finally Opens Its Way to Japan!
Biostar Stem Cell Research Institute, joint operated by R Bio and Nature Cell, announced that it has received approval on manufacture of processed specific cells on Feb. 10th.
Read moreBiostar Stem Cell Research Institute, joint operated by R Bio and Nature Cell, announced that it has received approval on manufacture of processed specific cells on Feb. 10th.
Read moreOn October 8, the Biostar Stem Cell Research Institute, jointly operated by Nature Cell and R Bio, announced that it has completed the application process for acquiring approval for treating degenerative arthritis with regenerative medicine.
Read moreOur organization was born again as R Bio, based on the resolution reached at the General Meeting of Shareholders held on June 29, 2015, and for this, we would like to extend our gratitude to all the stakeholders.
Read moreR-Japan Co., Ltd., a Japanese affiliate of Nature Cell, announced on November 25 that stem cell therapy in Japan has begun, using the adult stem cell technology developed by Korea’s Biostar Stem Cell Research Institute (President Dr. Ra Jeong-chan).
Read more
Most Commented